SVP & Controller Wyatt Christopher F. sold 4,000 HCA shares at $505.00 on 2026-02-11 for $2.0M
Wyatt Christopher F., SVP & Controller, sold 4,000 shares (-8.3% of pre-transaction holdings) at $505.00, reducing his HCA position from 48.4K to 44.4K shares. The transaction occurred as HCA stock stands at $535.22, off its 52-week low of $306.30 and matching its 52-week high, with strong recent momentum (+11.7% in 30 days, +13.2% in 90 days). His prior two sales at HCA in 2024 both showed positive 90-day returns (+0.9% and -1.5%, with only 1 of 2 well-timed at the 90-day mark), and cross-ticker his track record shows a 50% well-timed rate on sells with average 90-day negative return of -0.3%. The timing of this sale—at the 52-week high with sustained upward momentum—presents a contrasting signal compared to HCA fundamentals, which show revenue of $19.2B and net income of $1.6B with 7.1% annual revenue growth and a moderate P/E of 16.24.
SVP & Controller Wyatt Christopher F. sold 4,000 HCA shares at $360.20 on 2024-07-29; stock now at $358.73, near 52-week high.
Wyatt Christopher F., SVP & Controller, sold 4,000 shares (9.0% of pre-transaction holdings) at $360.20, reducing his stake from 44.4K to 40.4K shares. The sale occurred near the 52-week high of $358.73—the current price is +0.0% from that peak, indicating the insider sold at peak valuation. His prior sell at HCA on 2024-02-05 showed a 90-day return of -1.5%, consistent with his cross-ticker track record where 100.00% of his prior sells were well-timed (stock declined after sale). This sale pattern mirrors a prior disposition at the same ticker and occurs as HCA trades at robust fundamentals: P/E of 16.14, $17.5B quarterly revenue, and +7.9% annual growth. The timing proximity to 52-week highs warrants monitoring to determine whether this sale represents a consistent data point in his selling pattern or a discretionary rebalance.
